Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

2(22%)

Results Posted

40%(2 trials)

Phase Distribution

Ph phase_4

56%

Ph phase_3

11%

Ph not_applicable

11%

Ph phase_1

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

1(12.5%)

Phase 3Large-scale testing

1(12.5%)

Phase 4Post-market surveillance

5(62.5%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(5)

Other(1)

Detailed Status

Completed5

Recruiting1

Not yet recruiting1

unknown1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (12.5%)

Phase 31 (12.5%)

Phase 45 (62.5%)

N/A1 (12.5%)

Trials by Status

recruiting111%

not_yet_recruiting111%

unknown111%

active_not_recruiting111%

completed556%

Recent Activity

2 active trials

Showing 5 of 9

not_yet_recruitingphase_3

Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal Surgery

NCT07271875

active_not_recruitingnot_applicable

Emergence Agitation

NCT07253428

completedphase_4

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

NCT03909165

recruitingphase_1

Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

NCT06794450

completed

Sugammadex and Time to Extubation in Ophthalmic Surgery

NCT06632067

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT07271875Phase 3

Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal Surgery

Not Yet Recruiting

NCT07253428Not Applicable

Emergence Agitation

Active Not Recruiting

NCT03909165Phase 4

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

Completed

NCT06794450Phase 1

Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

Recruiting

NCT06632067

Sugammadex and Time to Extubation in Ophthalmic Surgery

Completed

NCT03351608Phase 4

Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)

Completed

NCT03144453Phase 4

Recovery From Anesthesia After Robotic Assisted Radical Cystectomy

Unknown

NCT02455921Phase 4

Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children

Completed

NCT01539044Phase 4

Optimal Relaxation Technique for Laparotomies With Rocuronium Infusion Followed by Sugammadex Reversal

Completed

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9